About this Medicine article
Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer by Graeven, U; Kremer, B; Südhoff, Th; Killing, B; Rojo, F; Weber, D; Tillner, J; ünal, C; Schmiegel, W is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Graeven, U; Kremer, B; Südhoff, Th; Killing, B; Rojo, F; Weber, D; Tillner, J; ünal, C; Schmiegel, W
- Publisher
- Nature Publishing Group; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0007-0920)
- Published
- 2006
- Field
- Medicine (Health Sciences)